Charles Anthony Laranjeira is CTO at Pacira Pharmaceuticals, Inc. (PCRX). They have made 8 open-market trades across 2 companies since 2013, most recently 2022-06-14.
CIK 0001524338
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PCRX | SELL | 2022-06-06 | 2022-06-08 | $60.33 | $888K | -9.5% | -2.7% | -12.5% |
| PCRX | SELL | 2021-06-04 | 2021-06-08 | $61.04 | $258K | -1.9% | -7.4% | -7.2% |
| PCRX | SELL | 2020-08-03 | 2020-08-05 | $52.68 | $132K | +15.5% | +12.3% | -1.6% |
| PCRX | SELL | 2020-06-29 | 2020-07-01 | $50.27 | $6.0M | -1.1% | -6.0% | +6.1% |
| PCRX | SELL | 2020-06-04 | 2020-06-08 | $46.33 | $40K | -6.4% | +18.8% | +26.3% |
| PCRX | SELL | 2019-06-04 | 2019-06-06 | $42.91 | $18K | +3.1% | +1.9% | -13.9% |
| CBST | SELL | 2013-05-20 | 2013-05-22 | $51.43 | $720K | N/A | N/A | N/A |
| CBST | SELL | 2013-02-19 | 2013-02-20 | $41.40 | $16K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.